Longeveron Inc. (LGVN)
NASDAQ · Manufacturing · Pharmaceutical preparations
LGVN price, last 12 months
Key stats
- Previous close
- $2.91
- Open
- $2.86
- Day range
- $2.76 – $2.95
- 52-week range
- $2.30 – $12.30
- Volume
- 45.7K
- Avg volume (20 days)
- 181.4K
- Market cap
- $9.0M
Performance
Technicals and fundamentals
About Longeveron Inc.
Longeveron Inc is a clinical stage biotechnology company developing regenerative medicines to address unmet medical needs. Its investigational product candidate is laromestrocel. Laromestrocel is a proprietary, scalable, allogeneic cellular therapy that has multiple potential modes of action that include pro-vascular, pro-regenerative, and anti-inflammatory mechanisms that collectively appear to promote tissue repair and healing. It is in clinical development of a single investigational product candidate, laromestrocel, for four potential indications: HLHS, Alzheimer's disease (AD), Pediatric Dilated Cardiomyopathy (pediatric DCM), and Aging-related Frailty. It operates in a single operating segment focused on developing regenerative medicines to address unmet medical needs.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $9.0M